nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—Cisplatin—germ cell cancer	0.339	0.419	CbGbCtD
Neostigmine—ABCB1—Dactinomycin—germ cell cancer	0.15	0.185	CbGbCtD
Neostigmine—ABCB1—Vinblastine—germ cell cancer	0.0939	0.116	CbGbCtD
Neostigmine—ABCB1—Cisplatin—germ cell cancer	0.0861	0.106	CbGbCtD
Neostigmine—ABCB1—Etoposide—germ cell cancer	0.0846	0.104	CbGbCtD
Neostigmine—ABCB1—Methotrexate—germ cell cancer	0.0559	0.069	CbGbCtD
Neostigmine—Salivation—Ifosfamide—germ cell cancer	0.00612	0.0389	CcSEcCtD
Neostigmine—Nystagmus—Vinblastine—germ cell cancer	0.0046	0.0293	CcSEcCtD
Neostigmine—Slurred speech—Cisplatin—germ cell cancer	0.00457	0.0291	CcSEcCtD
Neostigmine—Wheezing—Bleomycin—germ cell cancer	0.0027	0.0171	CcSEcCtD
Neostigmine—Dysarthria—Ifosfamide—germ cell cancer	0.00251	0.0159	CcSEcCtD
Neostigmine—ACHE—trigeminal ganglion—germ cell cancer	0.00238	0.0717	CbGeAlD
Neostigmine—Salivary hypersecretion—Ifosfamide—germ cell cancer	0.0023	0.0146	CcSEcCtD
Neostigmine—Urinary incontinence—Ifosfamide—germ cell cancer	0.00229	0.0146	CcSEcCtD
Neostigmine—Coma—Ifosfamide—germ cell cancer	0.00217	0.0138	CcSEcCtD
Neostigmine—Dysarthria—Cisplatin—germ cell cancer	0.00216	0.0137	CcSEcCtD
Neostigmine—Cardiovascular disorder—Etoposide—germ cell cancer	0.00213	0.0136	CcSEcCtD
Neostigmine—Chest discomfort—Etoposide—germ cell cancer	0.00212	0.0135	CcSEcCtD
Neostigmine—Wheezing—Cisplatin—germ cell cancer	0.00199	0.0126	CcSEcCtD
Neostigmine—ACHE—telencephalon—germ cell cancer	0.00187	0.0563	CbGeAlD
Neostigmine—Osteoarthritis—Ifosfamide—germ cell cancer	0.00172	0.0109	CcSEcCtD
Neostigmine—Bronchospasm—Bleomycin—germ cell cancer	0.00171	0.0109	CcSEcCtD
Neostigmine—Cardiac arrest—Ifosfamide—germ cell cancer	0.00164	0.0104	CcSEcCtD
Neostigmine—Paralysis—Methotrexate—germ cell cancer	0.00162	0.0103	CcSEcCtD
Neostigmine—ACHE—medulla oblongata—germ cell cancer	0.00147	0.0443	CbGeAlD
Neostigmine—Bronchospasm—Ifosfamide—germ cell cancer	0.00146	0.00931	CcSEcCtD
Neostigmine—Pollakiuria—Ifosfamide—germ cell cancer	0.00138	0.00874	CcSEcCtD
Neostigmine—ACHE—adrenal gland—germ cell cancer	0.00136	0.041	CbGeAlD
Neostigmine—ACHE—midbrain—germ cell cancer	0.00134	0.0405	CbGeAlD
Neostigmine—Cramp muscle—Cisplatin—germ cell cancer	0.00134	0.0085	CcSEcCtD
Neostigmine—ACHE—spinal cord—germ cell cancer	0.00131	0.0395	CbGeAlD
Neostigmine—Flushing—Bleomycin—germ cell cancer	0.00129	0.00823	CcSEcCtD
Neostigmine—Cardiac arrest—Etoposide—germ cell cancer	0.00129	0.00822	CcSEcCtD
Neostigmine—Sweating increased—Cisplatin—germ cell cancer	0.00125	0.00795	CcSEcCtD
Neostigmine—Convulsion—Vinblastine—germ cell cancer	0.00124	0.00792	CcSEcCtD
Neostigmine—Cramp muscle—Etoposide—germ cell cancer	0.00122	0.00779	CcSEcCtD
Neostigmine—Bradycardia—Ifosfamide—germ cell cancer	0.00121	0.00771	CcSEcCtD
Neostigmine—Flushing—Dactinomycin—germ cell cancer	0.00121	0.00767	CcSEcCtD
Neostigmine—Dysarthria—Methotrexate—germ cell cancer	0.00119	0.00754	CcSEcCtD
Neostigmine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00118	0.00748	CcSEcCtD
Neostigmine—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00117	0.00744	CcSEcCtD
Neostigmine—BCHE—trigeminal ganglion—germ cell cancer	0.00117	0.0353	CbGeAlD
Neostigmine—Urethral disorder—Ifosfamide—germ cell cancer	0.00117	0.00743	CcSEcCtD
Neostigmine—Bronchospasm—Etoposide—germ cell cancer	0.00116	0.00735	CcSEcCtD
Neostigmine—Sweating increased—Etoposide—germ cell cancer	0.00115	0.00728	CcSEcCtD
Neostigmine—ACHE—testis—germ cell cancer	0.00112	0.0339	CbGeAlD
Neostigmine—Flushing—Ifosfamide—germ cell cancer	0.00111	0.00703	CcSEcCtD
Neostigmine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00107	0.00683	CcSEcCtD
Neostigmine—Arrhythmia—Ifosfamide—germ cell cancer	0.00106	0.00677	CcSEcCtD
Neostigmine—Bradycardia—Cisplatin—germ cell cancer	0.00105	0.00665	CcSEcCtD
Neostigmine—Mental disorder—Ifosfamide—germ cell cancer	0.00104	0.00664	CcSEcCtD
Neostigmine—ACHE—cerebellum—germ cell cancer	0.00104	0.0313	CbGeAlD
Neostigmine—BCHE—brainstem—germ cell cancer	0.00104	0.0312	CbGeAlD
Neostigmine—Coma—Methotrexate—germ cell cancer	0.00103	0.00652	CcSEcCtD
Neostigmine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00101	0.00645	CcSEcCtD
Neostigmine—Connective tissue disorder—Cisplatin—germ cell cancer	0.00101	0.00642	CcSEcCtD
Neostigmine—Urethral disorder—Cisplatin—germ cell cancer	0.00101	0.0064	CcSEcCtD
Neostigmine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00099	0.0063	CcSEcCtD
Neostigmine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000959	0.0061	CcSEcCtD
Neostigmine—Flushing—Cisplatin—germ cell cancer	0.000953	0.00606	CcSEcCtD
Neostigmine—Agitation—Ifosfamide—germ cell cancer	0.000953	0.00606	CcSEcCtD
Neostigmine—Urinary tract disorder—Etoposide—germ cell cancer	0.000929	0.00591	CcSEcCtD
Neostigmine—Abdominal pain—Vinblastine—germ cell cancer	0.000927	0.00589	CcSEcCtD
Neostigmine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000926	0.00589	CcSEcCtD
Neostigmine—Hypotension—Bleomycin—germ cell cancer	0.000925	0.00588	CcSEcCtD
Neostigmine—Urethral disorder—Etoposide—germ cell cancer	0.000922	0.00586	CcSEcCtD
Neostigmine—BCHE—telencephalon—germ cell cancer	0.000919	0.0277	CbGeAlD
Neostigmine—Arrhythmia—Cisplatin—germ cell cancer	0.000918	0.00583	CcSEcCtD
Neostigmine—ABCB1—blood vessel—germ cell cancer	0.000902	0.0272	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000902	0.00574	CcSEcCtD
Neostigmine—Convulsion—Ifosfamide—germ cell cancer	0.000899	0.00571	CcSEcCtD
Neostigmine—Dyspnoea—Bleomycin—germ cell cancer	0.000883	0.00561	CcSEcCtD
Neostigmine—Arthralgia—Ifosfamide—germ cell cancer	0.000883	0.00561	CcSEcCtD
Neostigmine—Flatulence—Cisplatin—germ cell cancer	0.000881	0.0056	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000877	0.00558	CcSEcCtD
Neostigmine—BCHE—skin of body—germ cell cancer	0.000877	0.0264	CbGeAlD
Neostigmine—Flushing—Etoposide—germ cell cancer	0.000873	0.00555	CcSEcCtD
Neostigmine—Hypersensitivity—Vinblastine—germ cell cancer	0.000864	0.00549	CcSEcCtD
Neostigmine—Muscle spasms—Cisplatin—germ cell cancer	0.00086	0.00547	CcSEcCtD
Neostigmine—Mediastinal disorder—Etoposide—germ cell cancer	0.000848	0.00539	CcSEcCtD
Neostigmine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000846	0.00538	CcSEcCtD
Neostigmine—ACHE—brain—germ cell cancer	0.000843	0.0254	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000842	0.00535	CcSEcCtD
Neostigmine—Asthenia—Vinblastine—germ cell cancer	0.000841	0.00535	CcSEcCtD
Neostigmine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00083	0.00528	CcSEcCtD
Neostigmine—Skin disorder—Ifosfamide—germ cell cancer	0.000822	0.00523	CcSEcCtD
Neostigmine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000818	0.0052	CcSEcCtD
Neostigmine—ACHE—lymph node—germ cell cancer	0.000815	0.0246	CbGeAlD
Neostigmine—Osteoarthritis—Methotrexate—germ cell cancer	0.000815	0.00518	CcSEcCtD
Neostigmine—Diarrhoea—Vinblastine—germ cell cancer	0.000802	0.0051	CcSEcCtD
Neostigmine—Hypotension—Ifosfamide—germ cell cancer	0.000791	0.00503	CcSEcCtD
Neostigmine—Muscle spasms—Etoposide—germ cell cancer	0.000788	0.00501	CcSEcCtD
Neostigmine—Urticaria—Bleomycin—germ cell cancer	0.000787	0.005	CcSEcCtD
Neostigmine—Dizziness—Vinblastine—germ cell cancer	0.000775	0.00493	CcSEcCtD
Neostigmine—Convulsion—Cisplatin—germ cell cancer	0.000775	0.00493	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000771	0.0049	CcSEcCtD
Neostigmine—BCHE—uterus—germ cell cancer	0.000762	0.023	CbGeAlD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000756	0.00481	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000755	0.0048	CcSEcCtD
Neostigmine—Dyspnoea—Ifosfamide—germ cell cancer	0.000755	0.0048	CcSEcCtD
Neostigmine—Somnolence—Ifosfamide—germ cell cancer	0.000753	0.00478	CcSEcCtD
Neostigmine—BCHE—pituitary gland—germ cell cancer	0.000748	0.0225	CbGeAlD
Neostigmine—Vomiting—Vinblastine—germ cell cancer	0.000746	0.00474	CcSEcCtD
Neostigmine—Headache—Vinblastine—germ cell cancer	0.000735	0.00467	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000731	0.00465	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—germ cell cancer	0.00073	0.00464	CcSEcCtD
Neostigmine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00073	0.00464	CcSEcCtD
Neostigmine—Hypersensitivity—Bleomycin—germ cell cancer	0.00073	0.00464	CcSEcCtD
Neostigmine—BCHE—medulla oblongata—germ cell cancer	0.000722	0.0218	CbGeAlD
Neostigmine—Loss of consciousness—Etoposide—germ cell cancer	0.00072	0.00458	CcSEcCtD
Neostigmine—Nervous system disorder—Cisplatin—germ cell cancer	0.000716	0.00455	CcSEcCtD
Neostigmine—Tachycardia—Cisplatin—germ cell cancer	0.000712	0.00453	CcSEcCtD
Neostigmine—Asthenia—Bleomycin—germ cell cancer	0.000711	0.00452	CcSEcCtD
Neostigmine—Convulsion—Etoposide—germ cell cancer	0.00071	0.00451	CcSEcCtD
Neostigmine—Skin disorder—Cisplatin—germ cell cancer	0.000709	0.00451	CcSEcCtD
Neostigmine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000705	0.00449	CcSEcCtD
Neostigmine—Pruritus—Bleomycin—germ cell cancer	0.000701	0.00446	CcSEcCtD
Neostigmine—Nausea—Vinblastine—germ cell cancer	0.000697	0.00443	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000693	0.0044	CcSEcCtD
Neostigmine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000692	0.0044	CcSEcCtD
Neostigmine—Hypotension—Cisplatin—germ cell cancer	0.000682	0.00434	CcSEcCtD
Neostigmine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000681	0.00433	CcSEcCtD
Neostigmine—Urticaria—Ifosfamide—germ cell cancer	0.000672	0.00428	CcSEcCtD
Neostigmine—Abdominal pain—Ifosfamide—germ cell cancer	0.000669	0.00425	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—germ cell cancer	0.000669	0.00425	CcSEcCtD
Neostigmine—BCHE—adrenal gland—germ cell cancer	0.000668	0.0201	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000665	0.00423	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—germ cell cancer	0.000663	0.00421	CcSEcCtD
Neostigmine—BCHE—midbrain—germ cell cancer	0.00066	0.0199	CbGeAlD
Neostigmine—Tachycardia—Etoposide—germ cell cancer	0.000652	0.00415	CcSEcCtD
Neostigmine—Dyspnoea—Cisplatin—germ cell cancer	0.000651	0.00414	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—germ cell cancer	0.000649	0.00413	CcSEcCtD
Neostigmine—BCHE—bone marrow—germ cell cancer	0.000646	0.0195	CbGeAlD
Neostigmine—Hyperhidrosis—Etoposide—germ cell cancer	0.000646	0.00411	CcSEcCtD
Neostigmine—BCHE—spinal cord—germ cell cancer	0.000644	0.0194	CbGeAlD
Neostigmine—Diarrhoea—Dactinomycin—germ cell cancer	0.000632	0.00402	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00063	0.00401	CcSEcCtD
Neostigmine—Vomiting—Bleomycin—germ cell cancer	0.00063	0.004	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—germ cell cancer	0.000628	0.00399	CcSEcCtD
Neostigmine—Hypotension—Etoposide—germ cell cancer	0.000625	0.00397	CcSEcCtD
Neostigmine—Rash—Bleomycin—germ cell cancer	0.000624	0.00397	CcSEcCtD
Neostigmine—Dermatitis—Bleomycin—germ cell cancer	0.000624	0.00397	CcSEcCtD
Neostigmine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000624	0.00397	CcSEcCtD
Neostigmine—Asthenia—Ifosfamide—germ cell cancer	0.000607	0.00386	CcSEcCtD
Neostigmine—Pruritus—Ifosfamide—germ cell cancer	0.000599	0.00381	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—germ cell cancer	0.000596	0.00379	CcSEcCtD
Neostigmine—Somnolence—Etoposide—germ cell cancer	0.000594	0.00378	CcSEcCtD
Neostigmine—Nausea—Bleomycin—germ cell cancer	0.000588	0.00374	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—germ cell cancer	0.000587	0.00373	CcSEcCtD
Neostigmine—Rash—Dactinomycin—germ cell cancer	0.000582	0.0037	CcSEcCtD
Neostigmine—BCHE—endocrine gland—germ cell cancer	0.000579	0.0175	CbGeAlD
Neostigmine—Diarrhoea—Ifosfamide—germ cell cancer	0.000579	0.00368	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000577	0.00367	CcSEcCtD
Neostigmine—BCHE—head—germ cell cancer	0.000572	0.0172	CbGeAlD
Neostigmine—Dizziness—Ifosfamide—germ cell cancer	0.00056	0.00356	CcSEcCtD
Neostigmine—ABCB1—trigeminal ganglion—germ cell cancer	0.000557	0.0168	CbGeAlD
Neostigmine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000557	0.00354	CcSEcCtD
Neostigmine—BCHE—testis—germ cell cancer	0.000553	0.0167	CbGeAlD
Neostigmine—Urethral disorder—Methotrexate—germ cell cancer	0.000553	0.00351	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—germ cell cancer	0.000549	0.00349	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000547	0.00348	CcSEcCtD
Neostigmine—ABCB1—embryo—germ cell cancer	0.000538	0.0162	CbGeAlD
Neostigmine—Vomiting—Ifosfamide—germ cell cancer	0.000538	0.00342	CcSEcCtD
Neostigmine—Hypersensitivity—Cisplatin—germ cell cancer	0.000538	0.00342	CcSEcCtD
Neostigmine—Rash—Ifosfamide—germ cell cancer	0.000534	0.00339	CcSEcCtD
Neostigmine—Dermatitis—Ifosfamide—germ cell cancer	0.000533	0.00339	CcSEcCtD
Neostigmine—Urticaria—Etoposide—germ cell cancer	0.000531	0.00338	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—germ cell cancer	0.000528	0.00336	CcSEcCtD
Neostigmine—Asthenia—Cisplatin—germ cell cancer	0.000524	0.00333	CcSEcCtD
Neostigmine—BCHE—cerebellum—germ cell cancer	0.00051	0.0154	CbGeAlD
Neostigmine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000508	0.00323	CcSEcCtD
Neostigmine—Nausea—Ifosfamide—germ cell cancer	0.000503	0.0032	CcSEcCtD
Neostigmine—Diarrhoea—Cisplatin—germ cell cancer	0.000499	0.00317	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—germ cell cancer	0.000494	0.00314	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—germ cell cancer	0.000493	0.00313	CcSEcCtD
Neostigmine—Asthenia—Etoposide—germ cell cancer	0.00048	0.00305	CcSEcCtD
Neostigmine—ABCB1—retina—germ cell cancer	0.000476	0.0143	CbGeAlD
Neostigmine—Pruritus—Etoposide—germ cell cancer	0.000473	0.00301	CcSEcCtD
Neostigmine—Vomiting—Cisplatin—germ cell cancer	0.000464	0.00295	CcSEcCtD
Neostigmine—Rash—Cisplatin—germ cell cancer	0.00046	0.00293	CcSEcCtD
Neostigmine—Dermatitis—Cisplatin—germ cell cancer	0.00046	0.00292	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—germ cell cancer	0.000457	0.00291	CcSEcCtD
Neostigmine—Dizziness—Etoposide—germ cell cancer	0.000442	0.00281	CcSEcCtD
Neostigmine—ABCB1—telencephalon—germ cell cancer	0.000438	0.0132	CbGeAlD
Neostigmine—Nausea—Cisplatin—germ cell cancer	0.000433	0.00276	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—germ cell cancer	0.000425	0.0027	CcSEcCtD
Neostigmine—Vomiting—Etoposide—germ cell cancer	0.000425	0.0027	CcSEcCtD
Neostigmine—Rash—Etoposide—germ cell cancer	0.000422	0.00268	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—germ cell cancer	0.000421	0.00268	CcSEcCtD
Neostigmine—Headache—Etoposide—germ cell cancer	0.000419	0.00266	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—germ cell cancer	0.000418	0.00266	CcSEcCtD
Neostigmine—ABCB1—decidua—germ cell cancer	0.000415	0.0125	CbGeAlD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000415	0.00264	CcSEcCtD
Neostigmine—BCHE—brain—germ cell cancer	0.000415	0.0125	CbGeAlD
Neostigmine—BCHE—lymph node—germ cell cancer	0.000401	0.0121	CbGeAlD
Neostigmine—Anaphylactic shock—Methotrexate—germ cell cancer	0.0004	0.00255	CcSEcCtD
Neostigmine—Nausea—Etoposide—germ cell cancer	0.000397	0.00252	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—germ cell cancer	0.000393	0.0025	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—germ cell cancer	0.000389	0.00247	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000387	0.00246	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—germ cell cancer	0.000374	0.00238	CcSEcCtD
Neostigmine—ABCB1—gonad—germ cell cancer	0.000365	0.011	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000365	0.00232	CcSEcCtD
Neostigmine—ABCB1—uterus—germ cell cancer	0.000363	0.0109	CbGeAlD
Neostigmine—Insomnia—Methotrexate—germ cell cancer	0.000362	0.0023	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—germ cell cancer	0.000357	0.00227	CcSEcCtD
Neostigmine—ABCB1—pituitary gland—germ cell cancer	0.000356	0.0107	CbGeAlD
Neostigmine—Somnolence—Methotrexate—germ cell cancer	0.000356	0.00226	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000346	0.0022	CcSEcCtD
Neostigmine—ABCB1—medulla oblongata—germ cell cancer	0.000344	0.0104	CbGeAlD
Neostigmine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000327	0.00208	CcSEcCtD
Neostigmine—ABCB1—adrenal gland—germ cell cancer	0.000318	0.0096	CbGeAlD
Neostigmine—Urticaria—Methotrexate—germ cell cancer	0.000318	0.00202	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—germ cell cancer	0.000317	0.00201	CcSEcCtD
Neostigmine—ABCB1—midbrain—germ cell cancer	0.000314	0.00948	CbGeAlD
Neostigmine—ABCB1—bone marrow—germ cell cancer	0.000308	0.00929	CbGeAlD
Neostigmine—ABCB1—spinal cord—germ cell cancer	0.000307	0.00925	CbGeAlD
Neostigmine—ABCB1—female gonad—germ cell cancer	0.000297	0.00895	CbGeAlD
Neostigmine—Hypersensitivity—Methotrexate—germ cell cancer	0.000295	0.00188	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—germ cell cancer	0.000287	0.00183	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—germ cell cancer	0.000283	0.0018	CcSEcCtD
Neostigmine—ABCB1—endocrine gland—germ cell cancer	0.000276	0.00832	CbGeAlD
Neostigmine—Diarrhoea—Methotrexate—germ cell cancer	0.000274	0.00174	CcSEcCtD
Neostigmine—ABCB1—head—germ cell cancer	0.000273	0.00822	CbGeAlD
Neostigmine—Dizziness—Methotrexate—germ cell cancer	0.000265	0.00168	CcSEcCtD
Neostigmine—ABCB1—testis—germ cell cancer	0.000263	0.00794	CbGeAlD
Neostigmine—Vomiting—Methotrexate—germ cell cancer	0.000255	0.00162	CcSEcCtD
Neostigmine—Rash—Methotrexate—germ cell cancer	0.000252	0.00161	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—germ cell cancer	0.000252	0.0016	CcSEcCtD
Neostigmine—Headache—Methotrexate—germ cell cancer	0.000251	0.00159	CcSEcCtD
Neostigmine—ABCB1—cerebellum—germ cell cancer	0.000243	0.00733	CbGeAlD
Neostigmine—Nausea—Methotrexate—germ cell cancer	0.000238	0.00151	CcSEcCtD
Neostigmine—ABCB1—brain—germ cell cancer	0.000198	0.00596	CbGeAlD
Neostigmine—ABCB1—lymph node—germ cell cancer	0.000191	0.00575	CbGeAlD
